<DOC>
	<DOCNO>NCT00421720</DOCNO>
	<brief_summary>This prospective , randomize , multicenter , open-label study compare two analgesia-based regimen sedation ( remifentanil/propofol vs. sufentanil/propofol ) medium long-term ventilate intensive care patient term efficacy , safety resource utilization . The special characteristic intensive care patient ( organ insufficiency etc . ) regularly cause accumulation analgesic , sedatives adjuvant use . Clinically , complicate calculation wean extubation time , often make mechanical ventilation necessary long period desire also extend stay patient intensive care unit . Reducing wean time duration intensive care treatment optimize analgesia/sedation could furthermore lead reduction typical complication ventilator-associated pneumonia delirium . The demand ideal analgesic analgesic efficacy without severe cardiopulmonary depression rapid onset effect particular short dura-tion effect absence accumulation development active metabolite . Remifentanil ultra-short act µ-agonist , due molecular structure , metabolize organ-independently unspecific blood tissue esterases substance degrade within minute result metabolite virtually ineffective µ-receptor . Sufentanil , hand , mainly metabolize cytochrome P-450-3A4 enzyme liver small intestine . To date , one study small sample size available comparison effectiveness safety remifentanil sufentanil use long-term analgesia/sedation .</brief_summary>
	<brief_title>A Study Comparing Two Analgesia/Sedation Regimens , Remifentanil/Propofol Versus Sufentanil/Propofol In Mechanically Ventilated Intensive Care Patients Requiring Analgesia And Sedation .</brief_title>
	<detailed_description />
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<mesh_term>Sufentanil</mesh_term>
	<criteria>INCLUSION CRITERIA Written inform consent obtain patient The patient intensive medical care , intubate ventilate The expected duration ventilation analgesia/sedation &gt; 24 hour &lt; /= 7 day Propofol plan use sedative EXCLUSION CRITERIA Contraindication administration remifentanil , sufentanil , propofol Concomitant medication : The patient receive epidural analgesia peripheral regional anesthetic therapy . The patient require muscle relaxant facilitate mechanical ventilation The patient participate clinical drug trial within previous 30 day participate clinical trial currently participate clinical trial The patient know hypersensitivity drug investigation propofol ( component preparation use ) , soy peanut For female patient : patient pregnant breastfeed The patient classify ASA V moribund The patient must expect show impaired cerebral neurologic capacity due illness , trauma intervention , interfere collection analgesia/sedation score wake behavior example , without limit : Hypoxic brain damage Cerebrocranial trauma grade II , III , IV Subarachnoid hemorrhage , brainstem hemorrhage , ischemichemorrhagic cerebral hemorrhage Amyotrophic lateral sclerosis , myasthenia gravis Stupor coma The patient require chronic ventilation The patient receive chronic ( &gt; 3 month ) therapy highpotency opioids/WHO level 3 The patient alcohol drug dependent ( legal illegal drug particular , exclusively dependency sedative benzodiazepine ) , define : Typically urgent desire take substance , problem control consumption , persistent use substance despite adverse consequence . The use substance priority activity responsibility . Developing increased tolerance occasionally physical withdrawal symptom . The patient suffers manifest organ failure The patient suffers severe heart failure , NYHA Class IV ( symptoms rest ) The patient history actually suffer ventricular tachycardia , ventricular flutter ventricular fibrillation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>remifentanil</keyword>
	<keyword>sufentanil</keyword>
	<keyword>propofol</keyword>
	<keyword>analgesia</keyword>
	<keyword>sedation</keyword>
	<keyword>mechanically ventilate</keyword>
	<keyword>intensive care</keyword>
	<keyword>pharmacoeconomic</keyword>
	<keyword>wean</keyword>
	<keyword>delirium</keyword>
	<keyword>randomize</keyword>
	<keyword>Germany</keyword>
</DOC>